A Comparative Study between Serum Cystatin C and Microalbuminuria in the Diagnosis of Nephropathy in Type 2 Diabetes Mellitus
Annals of African Medicine · 2026
DOI: 10.4103/aam.aam_457_25 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Annals of African Medicine, 2026. Verfasst von Shiny Manuel und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Vinayaka Mission's Kirupananda Variyar Medical College and Hospitals, Vinayaka Mission's Research Foundation (DU), Salem,…. Hauptthemen laut MEDLINE: Cystatin C, Diabetes Mellitus, Type 2, Albuminuria, Diabetic Nephropathies. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
Diabetic nephropathy is the most serious complication associated with diabetes mellitus and the diagnosis typically relies on the identification of albuminuria. However, there are cases of renal insufficiency without albuminuria reported in diabetic patients. This study aimed to evaluate the association between microalbuminuria and serum cystatin C, as well as to assess the clinical usefulness of cystatin C in predicting the renal impairment in diabetic patients. Materials and Methods: It was a cross-sectional study conducted on type 2 diabetic patients and healthy controls, who were categorized into four groups based on their albuminuria levels. All the participants were investigated for serum cystatin C, albuminuria, and traditional markers of nephropathy.
Results
The level of cystatin C was significantly elevated in diabetic patients as compared to healthy individuals. The mean ± standard deviation progressively raised among the normoalbuminuric diabetic patients (1.32 ± 0.32 mg/L) and reached the peak in nephropathy patients (1.86 ± 0.25 mg/L). There was a significant positive correlation of cystatin C with albuminuria ( P < 0.001). Receiver operating characteristic analysis of cystatin C showed an area under the curve of 0.881 (95% confidence interval, 0.832–0.930) with a sensitivity of 80.83% and a specificity of 86.67%, demonstrating the diagnostic efficacy of cystatin C ( P < 0.001).
Conclusion
Elevated serum cystatin C level was observed in type 2 diabetic patients before the development of notable albuminuria, and its concentration rises as nephropathy advances, indicating that cystatin C could serve as a potential and earlier marker of renal dysfunction compared to albuminuria.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, Vinayaka Mission's Kirupananda Variyar Medical College and Hospitals, Vinayaka Mission's Research Foundation (DU), Salem, Tamil Nadu, India.
- Dr. Somervell Memorial CSI Medical College Hospital, Thiruvananthapuram, India.
- Pushpagiri Institute of Medical Sciences and Research Centre, Thiruvalla, India.
- Department of Pathology, Vinayaka Mission's Kirupananda Variyar Medical College and Hospitals, Vinayaka Mission's Research Foundation (DU), Salem, Tamil Nadu, India.
- Department of Zoology, Government College, Kottayam, Kerala, India.
Zitieren
APA
Manuel, S., Vijayasamundeeswari, C. K., Johnson, A., Johnson, A., Ramachandran, T., & Shiny, K. J. (2026). A Comparative Study between Serum Cystatin C and Microalbuminuria in the Diagnosis of Nephropathy in Type 2 Diabetes Mellitus. Annals of African Medicine. https://doi.org/10.4103/aam.aam_457_25
Vancouver
Manuel S, Vijayasamundeeswari CK, Johnson A, Johnson A, Ramachandran T, Shiny KJ. A Comparative Study between Serum Cystatin C and Microalbuminuria in the Diagnosis of Nephropathy in Type 2 Diabetes Mellitus. Annals of African Medicine. 2026. doi:10.4103/aam.aam_457_25
BibTeX
@article{Manuel2026,
author = {Manuel, Shiny and Vijayasamundeeswari, C K and Johnson, Anita and Johnson, Amal and Ramachandran, Thamilselvi and Shiny, K J},
title = {A Comparative Study between Serum Cystatin C and Microalbuminuria in the Diagnosis of Nephropathy in Type 2 Diabetes Mellitus},
journal = {Annals of African Medicine},
year = {2026},
doi = {10.4103/aam.aam_457_25}
}
EUVIMED